Market open· · ZAc · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Despite a decline in operating profit, Dis-Chem Pharmacies Ltd (JSE:DCP) showcases robust revenue growth and strategic advancements in digital transformation and market share expansion.
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...
Dis-Chem Pharmacies' (JSE:DCP) stock up by 9.1% over the past three months. Given that the market rewards strong...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.